Open Book Extracts

In a massive move for the hemp industry, Azuca, known for its innovative infusions in the THC domain, has joined forces with Open Book Extracts (OBX), a leader in cannabinoid extraction and product manufacturing. This collaboration could transform the hemp-derived delta-9 THC market by...

Open Book Extracts (OBX), a cannabinoid product manufacturer, has inked a term sheet to acquire Nucl3o, a processor of high-purity cannabinoid isolates, Benzinga Cannabis has learned exclusively. This acquisition marks a significant move in the cannabinoid industry, as it combines OBX's large-...

A historic alliance of top cannabidiol (CBD) companies advocating for legislation and FDA regulation of hemp-derived CBD products as dietary supplements launched Tuesday. The alliance, ONE HEMP, includes some of the biggest names in the space, like Charlotte’s Web (OTCQX:...

Humble & Fume Shakes Up Management Team Cannabis operator Humble & Fume Inc. (CSE: HMBL) (OTCQX: HUMBF) has appointed Chris Candelario as the president of US distribution. Candelario is a veteran of nearly twenty years in the distribution industry. "Providing exceptional service is my...

Equilibria Strengthens Women's Wellness With New CSO Equilibria named its first chief science officer, Dr. Jacqueline Jacques, a wellness industry veteran who will help the leadership team drive product development beyond hemp and design holistic coaching protocols to amplify women's...

Open Book Extracts launched a placebo-controlled trial of minor cannabinoid formulations to improve relaxation and calmness. The most prevalent mental health disorder in the world is anxiety. Globally, an estimated 284 million people experienced anxiety disorders in 2017, with women being diagnosed...

Open Book Extracts, announced the launch of its third trial on rare cannabinoids, in partnership with Radicle Science. Radicle Science is conducting the four-week blinded, randomized, placebo-controlled, institutional review board approved trial comparing the effects of various OBX cannabinoid...

Purissima, announced the official commercialization and sample availability of their cannabichromene (CBC) in partnership with Open Book Extracts. This launch follows the unveiling of Purissima's exclusive, multi-year processing and distribution partnership with OBX that was announced in July....

Open Book Extracts, launched new edible products powered by Unlokt from Day Three Labs. Unlokt is a novel, protein-based infusion technology that uses a fully water soluble powder that contains clean, all natural food grade ingredients. The powder can be easily incorporated into a wide range of...

Open Book Extracts (OBX) entered into a R&D and commercialization partnership with Nalu Bio. The partnership with OBX will allow Nalu Bio to advance its THCV production method from research and development to commercial-scale manufacturing using their proprietary and scalable synthesis platform...

As Benzinga Cannabis Capital Conference returns (September 13-14) in Chicago, gathering top CEOs, investors, and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space. Khiron Taps Helen Bellwood To Be Interim CFO Khiron Life Sciences Corp. (TSXV:...

Radicle Science, an AI-driven healthtech B-corp revealed the results of cannabinoid clinical trial on pain, in partnership with Open Book Extracts (OBX). All formulations in the pain study on CBD and rare cannabinoids were supplied by OBX, a NSF-certified manufacturer and distributor of cannabinoid...

Open Book Extracts (OBX) entered into a partnership with Biopharmaceutical Research Company (BRC). Under the terms of the collaboration, OBX will leverage BRC's research platforms, in order to develop research-backed formulations and products including Delta-9 THC. From preclinical and first-in...

Open Book Extracts announced the first close of a Series C equity financing round led by KEY Investment Partners. The financing will be used to expand finished goods manufacturing capabilities, to support ongoing and new safety studies and efficacy research and to accelerate international...

Open Book Extracts completed its first randomized, controlled trial on rare cannabinoids, with the support of Radicle Science. Radicle Science conducted a Radicle Discovery study on several OBX formulations. The study was a four-week blinded, randomized, controlled, parallel group comparison of the...